LncRNA FOXD2-AS1 promotes cell proliferation and invasion of fibroblast-like synoviocytes by regulation of miR-331-3p/PIAS3 pathway in rheumatoid arthritis

References

• Bullock J, Rizvi SAA, Saleh AM, et al. Rheumatoid arthritis: A brief overview of the treatment. medical principles and practice: international journal of the Kuwait University. Health Science Centre. 2018;27(6):501–507.
   Google Scholar
• Gibofsky A. Epidemiology, pathophysiology, and diagnosis of rheumatoid arthritis: A Synopsis. Am J Managed Care. 2014;20(7 Suppl):S128–S35.
   PubMed Web of Science ®Google Scholar
• Picerno V, Ferro F, Adinolfi A, et al. One year in review: the pathogenesis of rheumatoid arthritis. Clin Exp Rheumatol. 2015;33(4):551–558.
   PubMed Web of Science ®Google Scholar
• Tadin T, Nikolić H, Bosak Veršić A, et al. Psoas abscess as the first manifestation of Crohn’s disease–case report. Signa Vitae. 2018;14(2):78–79.
   Web of Science ®Google Scholar
• Bartok B, Firestein GS. Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis. Immunol Rev. 2010;233(1):233–255.
   PubMed Web of Science ®Google Scholar
• Yoshitomi H. Regulation of Immune Responses and Chronic Inflammation by Fibroblast-Like Synoviocytes. Front Immunol. 2019;10:1395.
   PubMed Web of Science ®Google Scholar
• Filer A. The fibroblast as a therapeutic target in rheumatoid arthritis. Curr Opin Pharmacol. 2013;13(3):413–419.
   PubMed Web of Science ®Google Scholar
• Hombach S, Kretz M. Non-coding RNAs: Classification, Biology and Functioning. Adv Exp Med Biol. 2016;937:3–17.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Xu YZ, Sun N, et al. Long noncoding RNA expression profile in fibroblast-like synoviocytes from patients with rheumatoid arthritis. Arthr Res Ther. 2016;18(1):227.
   PubMedGoogle Scholar
• Yang KY, Chen DL. Shikonin Inhibits Inflammatory Response in Rheumatoid Arthritis Synovial Fibroblasts via lncRNA-NR024118. Evidence-Based Complement Alternat Med: eCAM. 2015;2015:1–12.
   Web of Science ®Google Scholar
• Pan F, Zhu L, Lv H, et al. Quercetin promotes the apoptosis of fibroblast-like synoviocytes in rheumatoid arthritis by upregulating lncRNA MALAT1. Int J Mol Med. 2016;38(5):1507–1514.
   PubMed Web of Science ®Google Scholar
• Ye Y, Gao X, Yang N. LncRNA ZFAS1 promotes cell migration and invasion of fibroblast-like synoviocytes by suppression of miR-27a in rheumatoid arthritis. Human Cell. 2018;31(1):14–21.
   PubMed Web of Science ®Google Scholar
• Cao L, Wang Y, Wang Q, et al. LncRNA FOXD2-AS1 regulates chondrocyte proliferation in osteoarthritis by acting as a sponge of miR-206 to modulate CCND1 expression. Biomed Pharmacother. 2018;106:1220–1226.
   PubMed Web of Science ®Google Scholar
• Singh JA, Saag KG, Bridges SL, Jr, et al. 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis. Arthr Care Res. 2016;68(1):1–25.
   PubMed Web of Science ®Google Scholar
• World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191–2194.
   PubMed Web of Science ®Google Scholar
• Pap T, Franz JK, Hummel KM, et al. Activation of synovial fibroblasts in rheumatoid arthritis: lack of Expression of the tumour suppressor PTEN at sites of invasive growth and destruction. Arthr Res. 2000;2(1):59–64.
   PubMedGoogle Scholar
• Stanczyk J, Pedrioli DM, Brentano F, et al. Altered expression of MicroRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis. Arthr Rheumat. 2008;58(4):1001–1009.
   PubMed Web of Science ®Google Scholar
• Wei Q, Lv F, Zhang H, et al. MicroRNA-101-3p inhibits fibroblast-like synoviocyte proliferation and inflammation in rheumatoid arthritis by targeting PTGS2. Biosci Rep. 2020;40(1):BSR20191136.
   PubMedGoogle Scholar
• Ong CK, Lirk P, Tan CH, et al. An evidence-based update on nonsteroidal anti-inflammatory drugs. Clin Med Res. 2007;5(1):19–34.
   PubMedGoogle Scholar
• Smolen JS, Landewé R, Bijlsma J, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. Ann Rheumatic Dis. 2017;76(6):960–977.
   PubMed Web of Science ®Google Scholar
• Chung KC, Pushman AG. Current concepts in the management of the rheumatoid hand. The J Hand Surg. 2011;36(4):736–747.
   PubMedGoogle Scholar
• Araki Y, Mimura T. The mechanisms underlying chronic inflammation in rheumatoid arthritis from the perspective of the epigenetic landscape. J Immunol Res. 2016;2016:6290682.
   PubMed Web of Science ®Google Scholar
• Bottini N, Firestein GS. Duality of fibroblast-like synoviocytes in RA: passive responders and imprinted aggressors. Nat Rev Rheumatol. 2013;9(1):24–33.
   PubMed Web of Science ®Google Scholar
• Ren Z, Hu Y, Li G, et al. HIF-1α induced long noncoding RNA FOXD2-AS1 promotes the osteosarcoma through repressing p21. Biomed Pharmacother. 2019;117:109104.
   PubMed Web of Science ®Google Scholar
• Tse K, Ngan H. World trends of incidence of gynecologic malignancies in young women. Eur J Gynaecol Oncol. 2018;39(6):871–876.
   Web of Science ®Google Scholar
• Yang X, Duan B, Zhou X. Long non-coding RNA FOXD2-AS1 functions as a tumor promoter in colorectal cancer by regulating EMT and Notch signaling pathway. Eur Rev Med Pharmacol Sci. 2017;21(16):3586–3591.
   PubMed Web of Science ®Google Scholar
• Jiang M, Qiu N, Xia H, et al. Long non-coding RNA FOXD2-AS1/miR-150-5p/PFN2 axis regulates breast cancer malignancy and tumorigenesis. Int J Oncol. 2019;54(3):1043–1052.
   PubMed Web of Science ®Google Scholar
• Zhang H, Wang R, Wang M. miR-331-3p suppresses cell invasion and migration in colorectal carcinoma by directly targeting NRP2. Oncol Lett. 2019;18(6):6501–6508.
   PubMed Web of Science ®Google Scholar
• Epis MR, Giles KM, Candy PA, et al. miR-331-3p regulates expression of neuropilin-2 in glioblastoma. J Neuro-Oncol. 2014;116(1):67–75.
   PubMed Web of Science ®Google Scholar
• Chen X, Luo H, Li X, et al. miR-331-3p functions as an oncogene by targeting ST7L in pancreatic cancer. Carcinogenesis. 2018;39(8):1006–1015.
   PubMed Web of Science ®Google Scholar
• Kung LHW, Ravi V, Rowley L, et al. Cartilage microRNA dysregulation during the onset and progression of mouse osteoarthritis is independent of aggrecanolysis and overlaps with candidates from end-stage human disease. Arthritis Rheumatol. 2018;70(3):383–395.
   PubMed Web of Science ®Google Scholar
• Schmidt D, Müller S. PIAS/SUMO: new partners in transcriptional regulation. Cell Mol Life Sci. 2003;60(12):2561–2574.
   PubMed Web of Science ®Google Scholar
• Dabir S, Kluge A, Aziz MA, et al. Identification of STAT3-independent regulatory effects for protein inhibitor of activated STAT3 by binding to novel transcription factors. Cancer Biol Ther. 2011;12(2):139–151.
   PubMed Web of Science ®Google Scholar
• Lao M, Shi M, Zou Y, et al. Protein Inhibitor of Activated STAT3 Regulates Migration, Invasion, and Activation of Fibroblast-like Synoviocytes in Rheumatoid Arthritis. J Immunol (Baltimore, Md: 1950. ). 2016;196(2):596–606.
   PubMed Web of Science ®Google Scholar